Literature DB >> 2363588

[Renal puncture biopsy in nephrotic syndrome in Cameroonian children, adolescent and adults: histopathologic profile according to age].

A Mbakop1, T J Youmbissi, J D Gonsu, F Chatelanat, J L Ngu.   

Abstract

Eighty-six renal biopsies were under-taken in the Nephrology Service of the Yaounde Central Hospital (Cameroon, Central Africa) during a 4 year period (1st January 1986 to 31st of December 1989). Fifty of them (58%) were done in case of nephrotic syndrome associated or not with hypertension, renal failure. Only 42 of these 50 biopsies were valid and concerned 9 patients aged 8 to 15 years, 22 aged 16 to 30 years and 11 above 30 years. On the whole, 3 main lesions were noted: minimal changes (16 cases: 38.4%), membranous glomerulonephritis (13 cases: 31.2%) and proliferative glomerulonephritis (10 cases: 24%). From the analysis of lesions observed in each age group, it was found that the histopathologic profile of renal biopsies during nephrotic syndrome is practically identical in cameroonian children, young and adults with a relative predominance of minimal change and various glomerular lesions regardless of the age group.

Entities:  

Mesh:

Year:  1990        PMID: 2363588

Source DB:  PubMed          Journal:  Arch Anat Cytol Pathol        ISSN: 0395-501X


  3 in total

Review 1.  Malaria-induced renal damage: facts and myths.

Authors:  Jochen H H Ehrich; Felicia U Eke
Journal:  Pediatr Nephrol       Date:  2007-01-05       Impact factor: 3.714

2.  Epidemiology of Histologically Proven Glomerulonephritis in Africa: A Systematic Review and Meta-Analysis.

Authors:  Ikechi G Okpechi; Oluwatoyin I Ameh; Aminu K Bello; Pierre Ronco; Charles R Swanepoel; Andre P Kengne
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

3.  Kidney biopsy-based epidemiologic analysis shows growing biopsy rate among the elderly.

Authors:  Adél Molnár; Mbuotidem Jeremiah Thomas; Attila Fintha; Magdolna Kardos; Deján Dobi; András Tislér; Nóra Ledó
Journal:  Sci Rep       Date:  2021-12-29       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.